Barely Significant
← all excerpts

Engineering microparticles based on solidified stem cell secretome with an augmented pro-angiogenic factor portfolio for therapeutic angiogenesis.

Bioact Mater · 2022 · PMC9270501 · PMID 35846945

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
When applied to skin wound healing fibroblast-as well as MSC-derived ECM showed a trend towards better wound healing, although no significant differences in wound closure or revascularization were evident as compared to delivery vehicles lacking the respective cell-derived matrices [ 84 , 88 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.